Relfydess 150 units/ 1
As listed in the register: Relfydess 150 units/ 1,5 ml, Injektionslösung
·
- Prescription only
- Muscles, joints and bones
- Active substance
- Toxinum botulinicum A (stirpis I01)
- Used in
- Muscles, joints and bones
- Made by
- IPSEN Pharma Schweiz GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Zur vorübergehenden Verbesserung des Erscheinungsbildes von mittelstarken bis starken Glabellafalten bei maximalem Stirnrunzeln, mittelstarken bis starken seitlichen Canthallinien bei maximalem Lächeln, allein oder in Kombination, bei erwachsenen Patienten unter 65 Jahren, wenn das Ausmass dieser Falten eine erhebliche psychische Belastung für den Patienten darstellt.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | IPSEN Pharma Schweiz GmbH |
|---|---|
| Active substance | Toxinum botulinicum A (stirpis I01) |
| Used in | Muscles, joints and bones |
| Classification | M03AX01 · Muscles, joints and bones |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Relfydess 150 units/ 1,5 ml, Injektionslösung |
| Packs | 1 Durchstechflasche(n) · 10 Durchstechflasche(n) |
| Zulassungsnummer | 69620 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.